Demolition to start on former UK pharmaceutical plant

By Steve DuckerJanuary 05, 2021

Overview of the site where Maynards Europe will assist with asset recovery and demolition

Industrial auction and liquidation specialist Maynards Europe is to assist in asset recovery and demolition ahead of one of the United Kingdom’s most significant regeneration projects.

Work begins this month following the acquisition of the 40 ha (100 acre) Avlon Works pharmaceutical processing site by Canada-based Epta Development Corporation.

The works, at Bristol in the south of England, were operational for 50 years until most recent owner Avara Pharmaceutical went into administration in 2019. The asset list is 144 pages long and more than 5,000 lots are expected to be auctioned.

“The spares inventory alone is valued at more than £2.5 million (US$3.4 million), but add to that site support equipment, site infrastructure, offices, labs, warehouse equipment, workshops, data centres, building structures and much more, and it is easy to see just how substantial and significant this offer is,” said Maynards Europe UK managing director Daniel Gray.

Maynards Europe said it will work with logistics partners offering turnkey solutions to relocate and recommission equipment from the Avlon Works site globally.

Once cleared, the site will become a warehousing and logistics park.

MORE ARTICLES FROM CONEXPO-CON/AGG 365 NEWS
Four U.S. tower crane companies make the world’s top 25
Annual global ranking reflects growth in the crane sector and a general confidence in the construction market, despite unprecedented economic challenges
Komatsu’s newest small-size excavator is built for versatility in tight spaces
The PC78US-11 allows operators to quickly switch attachments with automatic adjustment of flow and pressure at the touch of a button 
Metallica, Carhartt team up for skilled trade worker recruitment
Harkening back to the metal band’s formation, the Labor Day employment drive was focused on combating the U.S. labor shortage in construction